72 related articles for article (PubMed ID: 12423564)
21. [The change of plasma level of endothelin-1 in patients with cor pulmonale and the effects of Captopril].
Chen W; Cheng D
Hua Xi Yi Ke Da Xue Xue Bao; 1999 Jun; 30(2):179-81. PubMed ID: 12212053
[TBL] [Abstract][Full Text] [Related]
22. Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction.
Holm P
Scand Cardiovasc J Suppl; 1997; 46():1-40. PubMed ID: 9265559
[TBL] [Abstract][Full Text] [Related]
23. [Effects of endothelin receptor antagonist on the hypoxic pulmonary hypertension].
Chen W; Cheng D
Hua Xi Yi Ke Da Xue Xue Bao; 2000 Sep; 31(3):370-2, 386. PubMed ID: 12545837
[TBL] [Abstract][Full Text] [Related]
24. [The role of endothelin the development of hypoxic pulmonary hypertension].
Xu J; Hou S; Chen S
Zhonghua Jie He He Hu Xi Za Zhi; 1995 Oct; 18(5):290-2, 318. PubMed ID: 8762482
[TBL] [Abstract][Full Text] [Related]
25. Chronic exposure to carbon monoxide and nicotine: endothelin ET(A) receptor antagonism attenuates carbon monoxide-induced myocardial hypertrophy in rat.
Loennechen JP; Nilsen OG; Arbo I; Aadahl P; Nilsen T; Waldum HL; Sandvik AK; Ellingsen O
Toxicol Appl Pharmacol; 2002 Jan; 178(1):8-14. PubMed ID: 11781074
[TBL] [Abstract][Full Text] [Related]
26. [Levels of plasma endothelin, nitric oxide and atrial natriuretic peptide after cardiopulmonary bypass and influence of inhaled nitric oxide in patients with ventricular septal defect and pulmonary hypertension].
Jiang H; Zhang R; Gong H; Ma Z; Li X; Song H
Zhonghua Wai Ke Za Zhi; 2002 Apr; 40(4):290-3. PubMed ID: 12133363
[TBL] [Abstract][Full Text] [Related]
27. Influence of applied tension and nitric oxide on responses to endothelins in rat pulmonary resistance arteries: effect of chronic hypoxia.
MacLean MR; McCulloch KM
Br J Pharmacol; 1998 Mar; 123(5):991-9. PubMed ID: 9535030
[TBL] [Abstract][Full Text] [Related]
28. Abnormalities of renal endothelin during acute exacerbation in chronic obstructive pulmonary disease.
Sofia M; Maniscalco M; Celentano L; Faraone S; Mormile M; Alifano M; Carratù L
Pulm Pharmacol Ther; 2001; 14(4):321-7. PubMed ID: 11440561
[TBL] [Abstract][Full Text] [Related]
29. [Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension].
Semenov AV; Kogan-Ponomarev MIa; Ruda MIa; Komarov AL; Panchenko EP; Chazova IE; Mazurov AV
Ter Arkh; 2000; 72(4):15-20. PubMed ID: 10833791
[TBL] [Abstract][Full Text] [Related]
30. [The change and distribution of endothelin-1 in lung of hypoxic pulmonary hypertension rat].
Yang X; Chen W; Li F
Hua Xi Yi Ke Da Xue Xue Bao; 2000 Mar; 31(1):30-3. PubMed ID: 12501606
[TBL] [Abstract][Full Text] [Related]
31. Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ET(A) receptor antagonist.
Tilton RG; Munsch CL; Sherwood SJ; Chen SJ; Chen YF; Wu C; Block N; Dixon RA; Brock TA
Pulm Pharmacol Ther; 2000; 13(2):87-97. PubMed ID: 10799286
[TBL] [Abstract][Full Text] [Related]
32. Circulating immunoreactive endothelin-1 in children with pulmonary hypertension. Association with acute hypoxic pulmonary vasoreactivity.
Allen SW; Chatfield BA; Koppenhafer SA; Schaffer MS; Wolfe RR; Abman SH
Am Rev Respir Dis; 1993 Aug; 148(2):519-22. PubMed ID: 8342919
[TBL] [Abstract][Full Text] [Related]
33. [The effect of acute pulmonary alveolar hypoxia on canine plasma endothelin-1 levels].
Cao W; Zeng Z; Luo W
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Oct; 16(5):356-60. PubMed ID: 7720127
[TBL] [Abstract][Full Text] [Related]
34. Venous endotelin-1 (ET-1) and brain natriuretic peptide (BNP) plasma levels during 6-month bosentan treatment for pulmonary arterial hypertension.
Vizza CD; Letizia C; Petramala L; Badagliacca R; Poscia R; Zepponi E; Crescenzi E; Nona A; Benedetti G; Ferrante F; Sciomer S; Fedele F
Regul Pept; 2008 Nov; 151(1-3):48-53. PubMed ID: 18796317
[TBL] [Abstract][Full Text] [Related]
35. Plasma adrenomedullin and endothelin-1 concentration during low-dose dobutamine infusion: Relationship between pulmonary uptake and pulmonary vascular pressure/flow characteristics.
Vizza CD; Letizia C; Badagliacca R; Sciomer S; Poscia R; Della Rocca G; Iacoboni C; Leonardo de L; Quattrucci S; Dario C; Luigi P; Fedele F
Regul Pept; 2006 Sep; 136(1-3):85-91. PubMed ID: 16815566
[TBL] [Abstract][Full Text] [Related]
36. The pathogenesis of pulmonary hypertension in haemodialysis patients via arterio-venous access.
Nakhoul F; Yigla M; Gilman R; Reisner SA; Abassi Z
Nephrol Dial Transplant; 2005 Aug; 20(8):1686-92. PubMed ID: 15840664
[TBL] [Abstract][Full Text] [Related]
37. Influence of valve replacement on plasma endothelin-1 level in mitral stenosis.
Snopek G; Pogorzelska H; Korewicki J
J Heart Valve Dis; 2000 Jan; 9(1):82-7. PubMed ID: 10678379
[TBL] [Abstract][Full Text] [Related]
38. Endothelin-1 across the lung circulation in patients with pulmonary arterial hypertension and influence of epoprostenol infusion.
Selimovic N; Andersson B; Bergh CH; Sakiniene E; Carlsten H; Rundqvist B
J Heart Lung Transplant; 2009 Aug; 28(8):808-14. PubMed ID: 19632577
[TBL] [Abstract][Full Text] [Related]
39. [A study of the effects of L-arginine in pathogenesis of hypoxic pulmonary hypertension].
Yang JP; Li HZ; Qi HW
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2000 Nov; 16(4):350-3. PubMed ID: 11236699
[TBL] [Abstract][Full Text] [Related]
40. Endothelin-A receptor blockade in porcine pulmonary hypertension.
Ambalavanan N; Philips JB; Bulger A; Oparil S; Chen YF
Pediatr Res; 2002 Dec; 52(6):913-21. PubMed ID: 12438670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
